Reverse cardiac remodeling after renal denervation: Atrial electrophysiologic and structural changes associated with blood pressure lowering

Heart Rhythm

Volumn 12, Issue 5, 2015, Pages 982-990

  McLellan, Alex J A ^a,b,c,d   Schlaich, Markus P ^a,b,e,f   Taylor, Andrew J ^a,b   Prabhu, Sandeep ^a,b,c,d   Hering, Dagmara ^b   Hammond, Louise ^b   Marusic, Petra ^b   Duval, Jacqueline ^b   Sata, Yusuke ^b   Ellims, Andris ^a,b   Esler, Murray ^a,b,e   Peter, Karlheinz ^a,b   Shaw, James ^a,b   Walton, Antony ^a,b   Kalman, Jonathan M ^c,d   Kistler, Peter M ^a,b,c,d  

^a ALFRED HOSPITAL   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e MONASH UNIVERSITY   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Atrial fibrillation; Cardiac magnetic resonance imaging; Electrophysiologic study; Remodeling; Renal denervation

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PROCEDURE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE DURATION; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART LEFT VENTRICLE MASS; HEART MUSCLE REFRACTORY PERIOD; HEART RATE VARIABILITY; HEART RIGHT ATRIUM; HEART VENTRICLE EXTRASYSTOLE; HOLTER MONITOR; HOLTER MONITORING; HUMAN; HYPERTENSION; KIDNEY DENERVATION; MALE; P WAVE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVERSE CARDIAC REMODELING; AGED; ATRIAL FIBRILLATION; COMPLICATION; DENERVATION; HEART ATRIUM; HEART ATRIUM REMODELING; HEART FUNCTION TEST; INNERVATION; KIDNEY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; ATRIAL REMODELING; BLOOD PRESSURE; DENERVATION; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FEMALE; HEART ATRIA; HUMANS; HYPERTENSION; KIDNEY; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84928473140     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.01.039     Document Type: Article

References (28)

1. V.L. Burt, P. Whelton, and E.J. Roccella et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991 Hypertension 25 Mar 1995 305 313
2. E.J. Benjamin, D. Levy, S.M. Vaziri, R.B. D'Agostino, A.J. Belanger, and P.A. Wolf Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study JAMA 271 1994 840 844
3. P.M. Kistler, P. Sanders, and M. Dodic et al. Atrial electrical and structural abnormalities in an ovine model of chronic blood pressure elevation after prenatal corticosteroid exposure: implications for development of atrial fibrillation Eur Heart J 27 2006 3045 3056
4. C. Medi, J.M. Kalman, and S.J. Spence et al. Atrial electrical and structural changes associated with longstanding hypertension in humans: implications for the substrate for atrial fibrillation J Cardiovasc Electrophysiol 22 2011 1317 1324
5. A.V. Chobanian, G.L. Bakris, and H.R. Black et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Hypertension 42 2003 1206 1252
6. M.D. Esler, H. Krum, P.A. Sobotka, M.P. Schlaich, R.E. Schmieder, and M. Bohm Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet 376 Dec 4 2010 1903 1909
7. M.P. Schlaich, D.M. Kaye, E. Lambert, M. Sommerville, F. Socratous, and M.D. Esler Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy Circulation 108 2003 560 565
8. T. Arimoto, H. Tada, and M. Igarashi et al. High washout rate of iodine-123-metaiodobenzylguanidine imaging predicts the outcome of catheter ablation of atrial fibrillation J Cardiovasc Electrophysiol 22 2011 1297 1304
9. H. Krum, M. Schlaich, and R. Whitbourn et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Lancet 373 2009 1275 1281
10. M.C. Brandt, F. Mahfoud, and S. Reda et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension J Am Coll Cardiol 59 2012 901 909
11. F. Mahfoud, D. Urban, and D. Teller et al. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial Eur Heart J 35 2014 2224 2231
12. A. Berruezo, D. Tamborero, and L. Mont et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation Eur Heart J 28 2007 836 841
13. E. Pokushalov, A. Romanov, and G. Corbucci et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension J Am Coll Cardiol 60 2012 1163 1170
14. D.L. Bhatt, D.E. Kandzari, and W.W. O'Neill et al. A controlled trial of renal denervation for resistant hypertension N Engl J Med 370 2014 1393 1401
15. D. Hering, E.A. Lambert, and P. Marusic et al. Substantial reduction in single sympathetic nerve firing after renal denervation in patients with resistant hypertension Hypertension 61 2013 457 464
16. M.P. Schlaich, P.A. Sobotka, H. Krum, E. Lambert, and M.D. Esler Renal sympathetic-nerve ablation for uncontrolled hypertension N Engl J Med 361 2009 932 934
17. M.P. Schneider, T.A. Hua, M. Bohm, K. Wachtell, S.E. Kjeldsen, and R.E. Schmieder Prevention of atrial fibrillation by renin-angiotensin system inhibition a meta-analysis J Am Coll Cardiol 55 2010 2299 2307
18. L.H. Ling, A.J. McLellan, and A.J. Taylor et al. Magnetic resonance post-contrast T1 mapping in the human atrium: Validation and impact on clinical outcome after catheter ablation for atrial fibrillation Heart Rhythm 11 2014 1551 1559
19. A. Menini, G.S. Slavin, J.A. Stainsby, P. Ferry, J. Felblinger, and F. Odille Motion correction of multi-contrast images applied to T1 and T2 quantification in cardiac MRI MAGMA 28 2015 1 12
20. N. Gai, E.B. Turkbey, and S. Nazarian et al. T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison Magn Reson Med 65 2011 1407 1415
21. F. Mahfoud, C. Ukena, and R.E. Schmieder et al. Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension Circulation 128 2013 132 140
22. D.E. Kandzari, D.L. Bhatt, and S. Brar et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial Eur Heart J 36 2015 219 227
23. S. Bull, S.K. White, and S.K. Piechnik et al. Human non-contrast T1 values and correlation with histology in diffuse fibrosis Heart 99 2013 932 937
24. L. Iles, H. Pfluger, and A. Phrommintikul et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping J Am Coll Cardiol 52 2008 1574 1580
25. D.H. Lau, L. Mackenzie, and D.J. Kelly et al. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model Heart Rhythm 7 2010 1282 1290
26. D. Linz, F. Mahfoud, and U. Schotten et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation Hypertension 61 2013 225 231
27. Y. Hou, J. Hu, and S.S. Po et al. Catheter-based renal sympathetic denervation significantly inhibits atrial fibrillation induced by electrical stimulation of the left stellate ganglion and rapid atrial pacing PLoS One 8 2013 e78218
28. R. Dabrowski, A. Borowiec, and E. Smolis-Bak et al. Effect of combined spironolactone-beta-blocker +/- enalapril treatment on occurrence of symptomatic atrial fibrillation episodes in patients with a history of paroxysmal atrial fibrillation (SPIR-AF study) Am J Cardiol 106 2010 1609 1614